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Introduction
Osteosarcoma, the most common primary malignant
tumor of bone in children and young adults, occurs
primarily in the long bones and typically metastasizes
to the lungs.1 However, non-pulmonary metastases
are being seen more often because of prolonged
longevity in osteosarcoma patients given modern
treatments.2 Tumor metastases to the orbit are found
mostly in adult carcinomas, and in children, in
embryonal tumors or sarcomas (most frequently
neuroblastoma, whereas Ewing’s sarcoma and Wilms’
tumor are less common).3 A MEDLINE review of the
literature revealed only 2 cases of osteosarcoma with
metastasis to the orbit.4,5 One patient with a primary
tumor in his right tibia developed protrusion of the
right eye 1 month after amputation of his leg. His
vision was normal. Further treatment was refused, and
the patient was discharged from hospital.4 The other
patient, who had primary pelvic telangiectatic
osteosarcoma and skull metastasis at diagnosis,
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developed right and then left orbital metastases 3 years
later; his vision was unaffected, but he had a constricted
visual field, and he died from the disease despite
radiotherapy.5 We report the third case of orbital
metastatic osteosarcoma, in which the patient’s vision
deteriorated rapidly. The clinical course and response
to treatment are described.
Case Report
A 15-year-old girl was referred to our hospital because
of progressive protrusion of her right eyeball since
October 2001. She had a history of osteosarcoma
(osteoblastic type) of the right proximal tibia; the con-
dition was first diagnosed in December 1999. A sys-
tematic work-up revealed no sign of distant metasta-
sis (stage IIB, according to the Musculoskeletal Tumor
Society staging system). Neoadjuvant chemotherapy
with ifosfamide, epirubicin, methotrexate and cisplatin
was administered, and surgery with wide excision, plus
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Figure 1. (A) Pre-contrast computed tomography (CT) scan showing
a soft tissue mass with calcification in the right orbit, middle
cranial fossa and infratemporal fossa; the right eyeball protruded
markedly. (B) Post-contrast, T1-weighted magnetic resonance
image showing a non-homogeneously enhanced mass. (C) Post-
contrast CT scan of the orbit after radiotherapy, chemotherapy
and partial removal of the tumor; the right eyeball is in a normal
position, without protrusion.
reconstruction with strut allograft arthrodesis, was
performed in April 2000.
The postoperative follow-up was uneventful until
October 2001, when painful protrusion of the right
eyeball appeared. A hypervascular mass in the right
orbit, middle cranial fossa, and infratemporal fossa,
was detected by imaging studies (Figure 1). Her best
corrected visual acuity was 20/200 (right eye) and
20/20 (left eye) at the initial presentation. Embo-
lization of the mass was performed 1 week later, with
more than 90% obliteration of tumor stains.
Nonetheless, her right-eye vision deteriorated to no
light perception after 1 month. Proptosis of the right
eyeball got worse, with movement limitation in all
directions. The right pupil was dilated without response
to light, but the right optic disc was still pinkish with
a clear margin. The posterior chorioretina was elevated
due to retrobulbar compression. The left eye was
normal. No signs of pulmonary metastasis or local
recurrence at the primary site were identified with
chest computed tomography (CT) and magnetic
resonance imaging (MRI) of the lower extremities.
Under the impression of osteosarcoma with orbital
and skull base metastases, the patient underwent radio-
therapy (4,000 cGy in 20 fractions), chemotherapy
with methotrexate, and then surgery for partial re-
moval of the tumor mass only, because the extensive
involvement of the skull base precluded complete
resection. Pathologic examinations suggested meta-
static osteosarcoma with extensive tumor necrosis
(Figure 2). The patient’s right-eye vision improved to
counting fingers (CF) at 50 cm, 1 month after the
completion of radiotherapy, but before chemotherapy
and surgery. The optic disc, however, became waxy
pale. The proptosis and limitation of eye movements
improved progressively to normal. Unfortunately, lung
metastases occurred in September 2002. The patient
underwent metastatectomy and chemotherapy. Tumor
metastasis to the right maxilla developed in April
2003. Local irradiation was administered. The patient’s
right-eye vision remained stable at around CF/50 cm
at the last follow-up visit in October 2003.
Discussion
Osteosarcoma was once a highly fatal bone sarcoma,
with more than 80% of patients dying from the disease
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within 5 years of diagnosis.6 However, as treatment
regimens have progressed, the life expectancy for
patients without metastases at presentation has
improved greatly.1 Such patients usually experience
subsequent pulmonary relapses, although non-
pulmonary metastases are increasing.2 The management
of relapsed patients includes aggressive metastatectomy
and chemotherapy, and some metastatic osteosarcomas
may be radiosensitive.7,8 Publications about the
management of orbital metastatic osteosarcoma are
rare. For primary orbital osteosarcoma, there has been
no conclusion about which treatment modality is best.
Further, patients with osteosarcoma of the head are
generally older than those with osteosarcoma of the
long bones, so responses to treatment might be
different.9 The proptosis in our patient regressed and
her vision improved after radiotherapy. The surgical
specimen, after radiotherapy and chemotherapy,
showed extensive tumor necrosis. Thus, combined
radiotherapy, chemotherapy and surgery can be
effective in the palliative treatment of orbital metastatic
osteosarcoma, whereas further clinical experience is
needed to define the potential role of embolization.
Metastatic rather than primary orbital tumors usually
lead to faster progression of proptosis, often associated
with pain, diplopia, and disturbances of ocular motility;
other symptoms include vision loss, ptosis, conjunctival
chemosis/injection, eyelid edema, and epiphora.3
Ocular symptoms and clinical data for the 3 reported
cases of orbital metastatic osteosarcoma are listed in
Table 1. Proptosis was observed in all 3 patients. Vi-
sual acuity ranged widely from normal to no light
perception. Since there are no lymphatic channels in
the retrobulbar area, metastatic tumors mainly reach
the orbit via hematogenous routes, although in
osteosarcoma, the most frequent site of metastasis is
the lung. However, in our patient, and in the case
reported by Misra et al,4 the lung was not involved at
the presentation of orbital metastasis. There was no
mention of whether the lung was involved in the case
reported by Mohadjer et al.5 Spreading of tumor to the
orbit, sparing the lung, has been suggested via Batson’s
paravertebral system.4 Further, multiple metastases to
other facial bones and the skull base can occur together
with orbital metastases, as observed in our patient and
in the case reported by Mohadjer et al.5
Figure 2. (A) Photomicrograph (after chemotherapy) of the primary tumor at the right proximal tibia; the chondroid component can still
be seen (hematoxylin & eosin, = 150). (B) The metastatic tumor (after radiotherapy and chemotherapy) at the skull base; the shadow
of necrotic tissue similar to osteosarcoma is demonstrated (hematoxylin & eosin, = 150).
Table 1. Characteristics of cases of orbital metastatic osteosarcoma
Case Authors
Age (yr)/ Primary
Histology
Duration* Orbital
Symptoms
Gender tumor (mo) metastasis
1 Misra et al4 8/M Right tibia N/A 6 Right Proptosis, normal vision
2 Mohadjer et al5 26/M Right pubis Telangiectatic 36 Bilateral Proptosis, visual field constriction,
third nerve palsy, optic atrophy
3 Lin et al (this report) 15/F Right tibia Osteoblastic 22 Right Proptosis, vision loss, optic atrophy
*From the presentation of the primary tumor to the occurrence of orbital metastasis.
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In conclusion, orbital metastasis of osteosarcoma,
although extremely rare in the past, should be con-
sidered when monitoring the condition of patients
with osteosarcoma. Indeed, non-pulmonary metastases
in osteosarcoma are increasing in prevalence because
of prolonged longevity in patients receiving modern
treatments. Proptosis is the most frequent sign of
orbital metastasis. Aggressive treatment with
chemotherapy, radiotherapy and surgical debulking
can relieve symptoms and possibly improve vision if it
is severely impaired. Further cases are needed to more
clearly define the clinical characteristics of osteosarcoma
with orbital metastases.
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